Tradeshow Voice - International and Asia Trade Shows for Manufacturers : The Lancet Asia Medical Forum 2007 The Lancet Asia Medical Forum 2007 ================================================================================ admin on 23 April, 2007 12 The Lancet Asia Medical Forum 2007 Asia & Cancer Management in the 21st Century City: Singapore Country: SINGAPORE Date : 21 April 2007 - 22 April 2007 http://www.asiamedicalforum.com/ The Lancet Asia Medical Forum 2007 will offer a unique opportunity for leading regional and international experts to come together with a unified goal of addressing the specific issues surrounding the provision, and future needs, of effective cancer care in Asia. The Forum will focus on the ten most prevalent cancers in Asia-Pacific and will examine aspects of prevention, diagnosis, treatment, and palliation. In addition, world opinion-leaders will discuss cancer aetiology, health-care systems, and the challenges of providing effective disease management with limited resources, along with views on state-of-the-art techniques in the areas of diagnostics, medical oncology, radiation therapy, and surgical oncology. Finally, the Forum will also host a didactic workshop on how to run a clinical trial, presented by world-renowned specialists, to help foster new clinical research. FORUM PROGRAMME SATURDAY, 21 APRIL 2007 INTRODUCTION 8:50 a.m. Dr Richard Horton Editor-in-Chief and Publisher, The Lancet, UK Mr Khaw Boon Wan Minister for Health, Singapore OPENING SESSION Moderator Dr Richard Horton Editor-in-Chief and Publisher, The Lancet, UK 9:10 a.m. Keynote Lecture 1 Cancer incidence: an Asian perspective Dr D Max Parkin Clinical Trials Service Unit & Epidemiological Studies Unit, University of Oxford, Oxford, UK 9:40 a.m. Asian cancer aetiology and prevention Prof Kazuo Tajima Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan 10:00 a.m. Clinical research in Asia: the importance of collaboration and the role of IARC and the WHO Dr Peter Boyle International Agency for Research on Cancer, Lyon, France 10:20 a.m. World Cancer Declaration and compliance in Asia: role of the UICC Dr Franco Cavalli International Union Against Cancer, Geneva, Switzerland 10:40 a.m. Role of multidisciplinary care and regional centres of excellence Prof Soo Khee Chee National Cancer Centre of Singapore, Singapore 11:00 a.m. Delivery of quality cancer care in countries with limited infrastructure Prof Ketayun Dinshaw Department of Radiation Oncology, Tata Memorial Hospital, Mumbai, India 11:20 a.m. TEA BREAK PREVENTION AND DIAGNOSIS I Moderator Prof Jatin P Shah Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA 11:50 a.m. H pylori, COX-2 inhibitors, and prevention of gastric cancer Prof Joseph J Sung Institute of Digestive Diseases, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong 12:10 p.m. Prevention and surveillance of hepatitis-B-related hepatocellular carcinoma Prof Yun-Fan Liaw Liver Research Unit, Chang Gung University, Taipei, Taiwan 12:30 p.m. 15 years of follow-up: what have we learned from the oesophageal Nutrition Intervention Trials in Linxian, China? Prof You-Lin Qiao Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences, Beijing, China 12:50 p.m. Oral cancers – Asian Perspective Prof Anil D’Cruz Head and Neck Services, Tata Memorial Hospital, Mumbai, India 1:10 p.m. Current developments in prevention strategies and diagnostics in colorectal cancer Prof Toshiaki Watanabe Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan 1:35 p.m. LUNCH AND POSTER SESSION I DISEASE MANAGEMENT I Moderator Prof Joseph J Sung Institute of Digestive Diseases, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong 2:35 p.m. Management of stomach cancer Prof Chew-Wun Wu Department of Surgery, Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan 2:55 p.m. Current management strategies for liver cancer Prof Morito Monden Department of Surgery, Osaka University, Osaka, Japan 3:15 p.m. Oesophageal cancer, East and West: same name, different disease Prof John Wong Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Hong Kong 3:35 p.m. State-of-the-art management of oral cancer and future challenges Prof Jatin P Shah Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA 3:55 p.m. Recent advances in colorectal cancer: where to from here? Prof John Zalcberg Department of Medical Oncology, Division of Haematology & Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia 4:20 p.m. TEA BREAK CLINICAL TRIALS IN ASIA Moderator Prof Steven Piantadosi Oncology Biostatistics, Johns Hopkins School of Medicine, Baltimore, MD, USA 4:50 p.m. Keynote Lecture 2: Opportunities for research in breast cancer in the developing world Prof Indraneel Mittra Bhopal Memorial Hospital and Research Centre, Bhopal, India 5:20 p.m. Workshop: Running a randomised clinical trial Chair Person: Prof Steven Piantadosi Oncology Biostatistics, Johns Hopkins School of Medicine, Baltimore, MD, USA Speakers include: Trial design, optimisation and data management Prof Steven Piantadosi Oncology Biostatistics, Johns Hopkins School of Medicine, Baltimore, MD, USA Improving recruitment to randomised clinical trials in cancer Prof Lesley Fallowfield Psychosocial Oncology Group, University of Sussex, Brighton, UK Trial infrastructure; Collaboration; Funding Prof Fred Hirsch University of Colorado Cancer Center, CO, USA Running an ethical trial Prof Maurie Markman The University of Texas MD Anderson Cancer Center, Houston, TX, USA Analysis; Data interpretation; Reporting Prof Masakazu Toi Department of Surgery [Breast Surgery], Graduate School of Medicine, Kyoto University, Kyoto, Japan 6:50 p.m. END OF DAY 1 SUNDAY, 22 APRIL 2007 OPENING SESSION Moderator Prof Sophie Fossa Norwegian Radium Hospital, Oslo, Norway 9:00 a.m. Keynote Lecture 3: Cancer management and traditional medicine Prof Tony Mok Department of Clinical Oncology, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong PREVENTION AND DIAGNOSIS II Moderator Prof Sophie Fossa Norwegian Radium Hospital, Oslo, Norway 9:30 a.m. Chemoprevention for lung cancer Prof Fred Hirsch University of Colorado Cancer Center, CO, USA 9:50 a.m. Diagnosis and prevention of breast cancer by nipple aspiration fluid Prof Masakazu Toi Department of Surgery (Breast Surgery), Graduate School of Medicine, Kyoto University, Kyoto, Japan 10:10 a.m. Strategies for cervical cancer prevention: the right one for the right community A/Prof Eng-Hseon Tay Department of Gynaecological Subspecialties and Gynaecological Oncology Unit, KK Women’s & Children’s Hospital, Singapore 10:30 a.m. Strategies for the prevention of ovarian cancer Prof Maurie Markman The University of Texas MD Anderson Cancer Center, Houston, TX, USA 10:50 a.m. Early diagnosis of prostate cancer without unnecessary treatment in those who will not benefit Prof James Denham University of Newcastle, Newcastle, Australia 11:15 a.m. TEA BREAK DISEASE MANAGEMENT II Moderator Prof Fred Hirsch University of Colorado Cancer Center, CO, USA 11:45 a.m. Treatment of advanced non-small-cell lung cancer with chemotherapy: An Asian experience Prof Sumitra Thongprasert Department of Medicine, Chiang Mai University, Chiang Mai, Thailand 12:05 p.m. The Breast Health Global Initiatives Foundation: clinical practice guidelines for the management of breast cancer in developing countries Prof Cheng-Har Yip Department of Surgery, University of Malaya Medical Centre, Kuala Lumpur, Malaysia 12:25 p.m . Management of cancer in uterine cervix Prof Chyong-Huey Lai Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan 12.45 p.m Salvage therapy of epithelial ovarian cancer: what is the appropriate setting for the Asian situation? Dr Sarikapan Wilailak Department of Obstetrics and Gynaecology, Ramathibodi Hospital, Bangkok, Thailand 1:05 p.m. Management of prostate cancer Prof Malcolm Mason Department of Oncology and Palliative Medicine, Wales College of Medicine, Cardiff University, Cardiff, UK 1:30 p.m. LUNCH AND POSTER SESSION II PALLIATIVE CARE AND QUALITY OF LIFE Moderator Prof Tony Mok Department of Clinical Oncology, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong 2:30 p.m. The need for oncologists and other doctors to learn about long-term effects after cancer Prof Sophie Fossa Norwegian Radium Hospital, Oslo, Norway 2:50 p.m. Why patient recorded quality of life data are more important parameters in trials? Prof Lesley Fallowfield Psychosocial Oncology Group, University of Sussex, Brighton, UK 3:10 p.m. The role of palliation and supportive care in effective cancer management Dr Nigel Sykes St Christopher Hospice, London, UK 3:30 p.m. Palliative care: An Asian perspective Dr Cynthia Goh Department of Palliative Medicine, National Cancer Centre Singapore, Singapore 3:50 p.m. The declaration of Venice: A global palliative care research initiative, with a special focus on developing countries Dr Marilẻne Filbet Palliative Care Unit, Central Hospital, University of Lyon, Lyon, France 4:10 p.m. TEA BREAK POSTER DISCUSSION SESSION Moderator Prof John Zalcberg Department of Medical Oncology, Division of Haematology and Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Australia 4:42 p.m. Effect of oral pilocarpine on treatment-related morbidity in patients receiving curative radiotherapy for head and neck cancers Dr Shikha Goyal Department of Radiotherapy and Oncology, All India Institute of Medical Sciences, New Delhi, India 4:49 p.m. New Prognostic Score to Predict Distant Metastasis in Nasopharyngeal Carcinoma Following Conformal Radiotherapy Dr Skye Cheng Department of Radiation Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan 4:56 p.m. 99mTc-Glucarate, a potential radiopharmaceutical for assessment of tumour viability: from bench to bedside Dr Partha Choudhury Department of Nuclear Medicine, Rajiv Gandhi Cancer Institute & Research Center, Delhi, India EMERGING TECHNOLOGIES AND ECONOMIC REALITIES Moderator Prof John Zalcberg Department of Medical Oncology, Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia 5:10 p.m. Non-FDG-based PET/CT in oncology Prof Peter Ell Institute of Nuclear Medicine, University College London Medical School, London, UK 5:30 p.m. The impact of molecular biology in new anticancer drug development Prof Gilberto Schwartsmann Hospital de Clinicas de Porto, Alegre Porto Alegre, Brazil 5:50 p.m. Integrating emerging technologies in emerging economies: the radiotherapy scenario A/Prof Rajiv Sarin Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Cancer Centre, Mumbai, India 6:10 p.m. Role of computer-assisted surgery in the present and future Dr. Khurshid Ahad Guru Roswell Park Cancer Institute, New York, USA 6:30 p.m. Keynote Lecture 4: Paying for modern cancer care – can we afford it? Prof Sir Michael Rawlins National Institute for Health & Clinical Excellence, London, UK 7:00 p.m. END OF FORUM Note: Programme subject to change.